IDEXX Laboratories, Inc. Stock
Equities
IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
497 USD | -0.56% | -3.79% | -10.47% |
May. 29 | Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference, May-29-2024 10:55 AM | |
May. 14 | Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620 | MT |
Financials (USD)
Sales 2024 * | 3.94B | Sales 2025 * | 4.34B | Capitalization | 41.04B |
---|---|---|---|---|---|
Net income 2024 * | 922M | Net income 2025 * | 1.04B | EV / Sales 2024 * | 10.5 x |
Net Debt 2024 * | 396M | Net Debt 2025 * | 223M | EV / Sales 2025 * | 9.51 x |
P/E ratio 2024 * |
44.9
x | P/E ratio 2025 * |
39.7
x | Employees | 11,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.19% |
Latest transcript on IDEXX Laboratories, Inc.
1 day | -0.56% | ||
1 week | -3.79% | ||
1 month | +0.85% | ||
3 months | -13.61% | ||
6 months | +6.68% | ||
Current year | -10.47% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 12-07-31 | |
Brian McKeon
DFI | Director of Finance/CFO | 61 | 03-06-30 |
John Hart
COO | Chief Operating Officer | - | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 14-03-10 |
M. Szostak
BRD | Director/Board Member | 73 | 12-07-15 |
Chairman | 61 | 16-10-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
8.32% | 1 M€ | -.--% | ||
1.59% | 17 M€ | +6.09% | - | |
1.14% | 2 M€ | -1.17% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 497 | -0.56% | 935,445 |
24-05-30 | 499.8 | +0.28% | 514,670 |
24-05-29 | 498.4 | -1.39% | 465,640 |
24-05-28 | 505.4 | -2.15% | 499,261 |
24-05-24 | 516.5 | +0.08% | 267,200 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
- Stock Market
- Equities
- IDXX Stock